Our intentions are noble – put patients at the forefront of our melanoma investigations to make their cure today’s reality. Our process is groundbreaking – use in-house, industry-quality research platforms to ensure that our breakthrough discoveries aren’t left sitting in academic research labs.

By combining Innovation, Collaboration and Scale, the Melanoma Moon Shot^®Thống kê lô gan is revolutionizing the conventional medical research approach to rapidly adapt pre-clinical findings into patient treatment options.

MELANOMA RESEARCH UPDATE

Pre-surgical therapy improves stage III melanoma outcomes

Thống kê lô ganA recent clinical trial demonstrated that a pair of targeted therapies given before and after surgery for stage III melanoma improved treatment outcomes beyond standard-of-care surgery. Several patients that received pre-surgical treatment achieved a pathological complete response (pCR), which means that no cancer was detected at the time of surgery. For those who didn't achieve pCR, this study used biopsies and blood samples to address why the treatment didn't work.